Nawsherwan Mohammad: Exploring Thrombophilia in 2026
Nawsherwan Mohammad, Consultant Hematopathologist at Nanakaly Hospital, shared a post on LinkedIn:
“Thrombophilia in 2026
The modern approach to thrombophilia emphasizes precision medicine, recommending selective testing only when the results are likely to influence clinical management.
Testing is appropriate for patients with unprovoked or recurrent VTE, thrombosis at unusual sites, recurrent pregnancy loss, a strong family history, or suspected antiphospholipid syndrome, while it is generally not recommended for provoked VTE, during acute thrombosis or anticoagulation, or as routine screening of relatives.
Current evaluation focuses on high-yield tests, including Factor V Leiden, Prothrombin G20210A, antithrombin, protein C and protein S deficiencies, and antiphospholipid antibodies.
Treatment decisions should be based primarily on the patient’s clinical risk rather than thrombophilia status alone.
High-risk thrombophilias often require specialist care and extended anticoagulation, while emerging evidence supports the use of DOACs in selected patients.
Special populations, particularly pregnant women and patients with antithrombin deficiency, require individualized risk assessment and multidisciplinary management.
Overall, thrombophilia testing should be purpose-driven, evidence-based, and tailored to improve patient outcomes rather than performed routinely.”
Stay updated with Hemosyasis Today.
-
Aug 24, 2026, 06:47Help Shape the Future of Light Transmission Aggregometry – ISTH
-
Aug 24, 2026, 06:31Wolfgang Miesbach: How Common Are Fabricated References in Research?
-
Aug 24, 2026, 06:16Juan Manuel Cisneros Carrasco: When Blood Is Needed, Is It Actually There?
-
Aug 24, 2026, 04:02William Wallace: Does Fish Oil Increase Atrial Fibrillation Risk?
-
Aug 24, 2026, 02:48Alexandru Stieber: Large-Vessel Vasculitis – Clinical Patterns and Treatment
-
Aug 23, 2026, 17:51Gurpreet Kaurr: A Proud Milestone in Haematology and Oncology
-
Aug 23, 2026, 17:33Kathrine Kaspersen: How Voluntary Plasma Donors Helped Transform Denmark’s Plasma Supply
-
Aug 23, 2026, 16:51Sthanu Subramanian: Empagliflozin and a Rise in Hematocrit
-
Aug 23, 2026, 16:50Lale Tokgözoğlu: New PCSK9i Research Published in the European Heart Journal